Docking and DFT Studies to explore the Topoisomerase II ATP Pocket employing 3-Substituted 2,6-Piperazindiones for drug design

References

• Fernández , A. , Crespo , A. and Tiwari , A. 2009 . Is there a case for selectively promiscuous anticancer drugs? . Drug Discov. Today , 14 : 1 – 5 .
   Web of Science ®Google Scholar
• Vermorken , J.B. 2001 . The integration of paclitaxel and new platinum compounds in the treatment of advanced ovarian cancer . Int. J. Gynecol. Cancer , 11 ( Suppl. 1 ) : 21 – 30 .
   Web of Science ®Google Scholar
• Forterre , P. , Bergerat , A. and Lopez-Garcia , P. 1996 . A new family of type II topoisomerase (VI) discovered in archaea and its eukaryotic homologues . FEMS Microbiol. Rev. , 18 : 237 – 248 .
   PubMed Web of Science ®Google Scholar
• Schoeffler , A.J. and Berger , J.M. 2008 . DNA topoisomerases: Harnessing and constraining energy to govern chromosome topology . Q. Rev. Biophys. , 41 : 41 – 101 .
   PubMed Web of Science ®Google Scholar
• Wang , J.C. 1982 . DNA topoisomerases . Sci. Am. , 247 : 94 – 97 . Idem 100–109
   PubMed Web of Science ®Google Scholar
• Pommier , Y. 2009 . DNA topoisomerase I inhibitors: Chemistry, biology, and interfacial inhibition . Chem. Rev. , 109 : 2894 – 2902 .
   PubMed Web of Science ®Google Scholar
• Liu , L.F. , Liu , C.C. and Alberts , B.M. 1980 . Type II DNA topoisomerases: Enzymes that can unknot a topologically knotted DNA molecule via a reversible double-strand break . Cell , 19 : 697 – 707 .
   PubMed Web of Science ®Google Scholar
• Hu , C.X. , Zuo , Z.L. , Xiong , B. , Ma , J.G. , Geng , M.Y. , Lin , L.P. , Jiang , H.L. and Ding , J. 2006 . Salvicine functions as novel topoisomerase II poison by binding to ATP pocket . Mol. Pharm. , 70 : 1593 – 1601 .
   PubMed Web of Science ®Google Scholar
• Wei , H. , Ruthenburg , A.J. , Bechis , S.K. and Verdine , G.L. 2005 . Nucleotide-dependent domain movement in the ATPase domain of a human type IIA DNA topoisomerase . J. Biol. Chem. , 280 : 37041 – 37047 .
   PubMed Web of Science ®Google Scholar
• Dias , R. and De Azevedo , W.F. Jr . 2008 . Molecular docking algorithms . Curr. Drug Targets , 9 : 1040 – 1047 .
   PubMed Web of Science ®Google Scholar
• Wang , W. , Rupasinghe , S.G. , Schuler , M.A. and Gonzalez de Mejia , E. 2008 . Identification and characterization of topoisomerase II inhibitory peptides from soy protein hydrolysates . J. Agric. Food Chem. , 13 : 6267 – 6277 .
   Web of Science ®Google Scholar
• Takasuga , Y. , Andoh , T. , Yamashita , J. and Yagura , T. 1995 . ICRF-193, an inhibitor of topoisomerase II, demonstrates that DNA replication in sperm nuclei reconstituted in Xenopus egg extracts does not require chromatin decondensation . Exp. Cell Res. , 217 : 378 – 384 .
   PubMed Web of Science ®Google Scholar
• Schneidman-Duhovny , D. , Dror , O. , Inbar , Y. , Nussinov , R. and Wolfson , H.J. 2008 . Deterministic pharmacophore detection via multiple flexible alignment of drug-like molecules . J. Comput. Biol. , 15 : 737 – 754 .
   PubMed Web of Science ®Google Scholar
• Singh , Y. , Palombo , M. and Sinko , P.J. 2008 . Recent trends in targeted anticancer prodrug and conjugate design . Curr. Med. Chem. , 15 : 1802 – 1826 .
   PubMed Web of Science ®Google Scholar
• Brewerton , S.C. 2008 . The use of protein–ligand interaction fingerprints in docking . Curr. Opin. Drug Discov. Devel. , 11 : 356 – 364 .
   PubMed Web of Science ®Google Scholar
• Ravna , A.W. and Sager , G. 2008 . Molecular model of the outward facing state of the human multidrug resistance protein 4 (MRP4/ABCC4) . Bioorg. Med. Chem. Lett. , 18 : 3481 – 3483 .
   Web of Science ®Google Scholar
• Creigton , A.M. , Hellmann , K. and Whitecross , S. 1969 . Antitumor activity in a series of bis-diketopiperazines . Nature , 222 : 384 – 385 .
   Web of Science ®Google Scholar
• Bellet , R.E. , Rozencweig , M. , Von Hoff , D.D. , Penta , J.S. , Wasserman , T.H. and Muggia , F.M. 1977 . ICRF-159 current status and clinical prospects . Eur. J. Cancer. , 13 : 1293 – 1298 .
   PubMed Web of Science ®Google Scholar
• Li , X.T. , Hutchinson , G.E. , Pym , B.A. , Finch , M. and Hellmann , K. 1983 . Effect of AT 1727 on growth and metastasis of murine tumours . Eur. J. Cancer Clin. Oncol. , 19 : 283 – 287 .
   PubMedGoogle Scholar
• Ren , Y.F. , Otter , G.M. and Schmid , F.A. 1985 . Further evaluation of bimolane and analogs as potential antitumor agents . Eur. J. Cancer Clin. Oncol. , 21 : 493 – 497 .
   Google Scholar
• Cai , J.C. , Shu , H.L. , Tang , C.F. , Komatsa , T. , Matsuno , T. , Narita , T. , Yaguchi , S. , Koide , Y. and Takase , M. 1989 . Synthesis and antitumor properties of N1-acyloxymethyl derivatives of bis(2,6-dioxopiperazines) . Chem. Pharm. Bull. , 37 : 2976 – 2983 .
   PubMed Web of Science ®Google Scholar
• Narita , T. , Yaguchi , S. , Komatsu , T. , Takase , M. , Hoshino , A. , Inaba , M. and Tsukagoshi , S. 1990 . Antitumor activity of MST-16, a novel derivative of bis(2,6-dioxopiperazine), in murine tumor models . Cancer Chemother. Pharmacol. , 26 : 193 – 197 .
   PubMed Web of Science ®Google Scholar
• Narita , T. , Koide , Y. , Yaguchi , S. , Kimurra , S. , Izumisawa , Y. , Takase , M. , Inaba , M. and Tsukagoshi , S. 1991 . Antitumor activities and schedule dependence of orally administered MST-16, a novel derivative of bis(2,6-dioxopiperazine), in murine tumor models . Cancer Chemother. Pharmacol. , 28 : 235 – 240 .
   PubMed Web of Science ®Google Scholar
• Ishida , R. , Miki , T. , Narita , T. , Yui , R. , Sato , M. , Utsumi , K.R. , Tanabe , K. and Andoh , T. 1991 . Inhibition of intracellular topoisomerase II by antitumor bis(2,6-dioxopiperazine) derivatives: Mode of cell growth inhibition distinct from that of cleavable complex-forming type inhibitors . Cancer Res. , 51 : 4909 – 4916 .
   PubMed Web of Science ®Google Scholar
• Kano , Y. , Narita , T. , Suzuki , K. , Akutsu , M. , Sudas , K. , Sakamoto , S. and Miura , Y. 1992 . The effects of ICRF-154 in combination with other anticancer agents in vitro . Br. J. Cancer , 66 : 281 – 286 .
   PubMed Web of Science ®Google Scholar
• Tanabe , K. , Ikegami , Y. , Ishida , R. and Andoh , T. 1991 . Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives . Cancer Res. , 51 : 4903 – 4908 .
   PubMed Web of Science ®Google Scholar
• Hasinoff , B.B. , Kuschak , T.I. , Yalowich , J.C. and Creighton , A.M. 1995 . A QSAR study comparing the cytotoxicity and DNA topoisomerase II inhibitory effects of bisdioxopiperazine analogs of ICRF-187 (dexrazoxane) . Biochem. Pharmacol. , 50 : 953 – 958 .
   PubMed Web of Science ®Google Scholar
• Hasinoff , B.B. , Kuschak , T.I. , Creighton , A.M. , Fattman , Ch.L. , William , P.A. , Hy , T.P. and Yalawich , J.C. 1997 . Characterization of a Chinese hamster ovary cell line with acquired resistance to the bisdioxopiperazine dexrazoxane (ICRF-187) catalytic inhibitor, of topoisomerase II . Biochem. Pharmacol. , 53 : 1843 – 1853 .
   PubMed Web of Science ®Google Scholar
• Khélifa , T. and Beck , W.T. 1999 . Induction of apoptosis by dexrazoxane (ICRF-187) through caspases in the absence of c-jun expression and c-Jun NH2-terminal kinase 1 (JNK1) activation in VM-26-resistant CEM cells-JNK activation is not linked to apoptosis while NF-κB activation prevents cell death . Biochem. Pharmacol. , 58 : 1247 – 1257 .
   PubMed Web of Science ®Google Scholar
• Del Fresno , M. , Alsina , J. , Royo , M. , Barany , G. and Albericio , F. 1998 . Solid-phase synthesis of diketopiperazines, useful scaffolds for combinatorial chemistry . Tetrahedron Lett. , 39 : 2639 – 2642 .
   Web of Science ®Google Scholar
• Mancilla , T. , Carrillo , L. , Zamudio-Rivera , L.S. , Beltrán , H.I. and Farfán , N. 2002 . Synthesis and characterization of piperazine-2,6-diones . Org. Prep. Proc. Int. , 34 : 87 – 94 .
   Web of Science ®Google Scholar
• Dinsmore , C.J. and Beshore , D.C. 2002 . Recent advances in the synthesis of diketopiperazines . Tetrahedron , 58 : 3297 – 3312 .
   Web of Science ®Google Scholar
• Shvedaite , I.P. and Shimkyavichene , V.I. 1999 . Synthesis and antitumor activity of 2,6-piperazinedione derivatives . Pharm. Chem. J. , 33 : 359 – 360 .
   Google Scholar
• Shvedaite , I.P. , Udrenaite , E.B. , Lauzhikene , N.A. and Gaidyalis , P.G. 1999 . Synthesis and antiinflammatory activity of 4-acyl- and 4-sulfonyl derivatives of piperazine-2,6-dione . Pharm. Chem. J. , 33 : 313 – 316 .
   Google Scholar
• Svedaite , I. 2007 . Synthesis and properties of some new 4-succinamoyl piperazine-2,6-dione derivatives . Chemija , 18 : 50 – 53 .
   Web of Science ®Google Scholar
• Izzo , P.T. and Safir , S.R. 1959 . The synthesis of some 3,3-dialkyl-2,6-piperazinediones . J. Am. Chem. Soc. , 81 : 4668 – 4670 .
   Web of Science ®Google Scholar
• Stewart , J.J.P. 1989 . Optimization of parameters for semi-empirical methods I-method . J. Comput. Chem. , 10 : 209 – 220 .
   Web of Science ®Google Scholar
• Stewart , J.J.P. 1989 . Optimization of parameters for semi-empirical methods II. applications . J. Comput. Chem. , 10 : 221 – 264 .
   Web of Science ®Google Scholar
• Frisch , M.J. , Trucks , G.W. , Schlegel , H.B. , Scuseria , G.E. , Robb , M.A. , Cheeseman , J.R. , Zakrzewski , V.G. , Montgomery , J.A. , Stratmann , R.E. , Burant , J.C. , Dapprich , S. , Millam , J.M. , Daniels , A.D. , Kudin , K.N. , Strain , M.C. , Farkas , O. , Tomasi , J. , Barone , V. , Cossi , M. , Cammi , R. , Mennucci , B. , Pomelli , C. , Adamo , C. , Clifford , S. , Ochterski , J. , Peterson , G.A. , Ayala , P.Y. , Cui , Q. , Morokuma , K. , Malick , D.K. , Rabuck , A.D. , Raghavachari , K. , Foresman , J.B. , Cioslowski , J. , Ortiz , J.V. , Baboul , A.G. , Stefanov , B.B. , Liu , G. , Liashenko , A. , Piskorz , P. , Komaromi , I. , Gomperts , R. , Martin , R.L. , Fox , D.J. , Keith , T. , Al-Laham , M.A. , Peng , C.Y. , Nanayakkara , A. , Challacombe , M. , Gill , P.M.W. , Johnson , B. , Chen , W. , Wong , M.W. , Andres , J.L. , Gonzalez , C. , Head-Gordon , M. , Replogle , E.S. and Pople , J.A. 1998 . Gaussian 98, Revision A.9 , Pittsburgh, PA : Gaussian, Inc. .
   Google Scholar
• Tomasi , J. , Mennucci , B. and Cammi , R. 2005 . Quantum mechanical continuum solvation models . Chem. Rev. , 105 : 2999 – 3093 .
   PubMed Web of Science ®Google Scholar
• Klamt , A. and Schüürmann , G. 1993 . COSMO: A new approach to dielectric screening in solvents with explicit expressions for the screening energy and its gradient . J. Chem. Soc. Perkin Trans. , 2 : 799 – 805 .
   Google Scholar
• Becke , A.D. 1993 . A new mixing of Hartree-Fock and local density-functional theories . J. Chem. Phys. , 98 : 1372 – 1377 .
   Web of Science ®Google Scholar
• Lee , C. , Yang , W. and Parr , R.G. 1988 . Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density . Phys. Rev. B , 37 : 785 – 789 .
   PubMed Web of Science ®Google Scholar
• Godbout , N. , Salahub , D.R. , Andzelm , J. and Wimmer , E. 1992 . Optimization of Gaussian-type basis sets for local spin density functional calculations. Part I. Boron through neon, optimization technique and validation . Can. J. Chem. , 70 : 560 – 571 .
   Web of Science ®Google Scholar
• Humphrey , W. , Dalke , A. and Schulten , K. 1996 . VMD – visual molecular dynamics . J. Mol. Graphics , 14 : 33 – 38 .
   PubMed Web of Science ®Google Scholar
• MacKerell , A.D. Jr , Bashford , D. , Bellott , M. , Dunbrack , R.L. Jr , Evanseck , J. , Field , M.J. , Fischer , S. , Gao , J. , Guo , H. , Ha , S. , Joseph , D. , Kuchnir , L. , Kuczera , K. , Lau , F.T.K. , Mattos , C. , Michnick , S. , Ngo , T. , Nguyen , D.T. , Prodhom , B. , Reiher , I.W.E. , Roux , B. , Schlenkrich , M. , Smith , J. , Stote , R. , Straub , J. , Watanabe , M. , Wiorkiewicz-Kuczera , J. , Yin , D. and Karplus , M. 1998 . All-atom empirical potential for molecular modeling and dynamics studies of proteins . J. Phys. Chem. B , 102 : 3586 – 3616 .
   PubMed Web of Science ®Google Scholar
• Phillips , J.C. , Braun , R. , Wang , W. , Gumbart , J. , Tajkhorshid , E. , Villa , E. , Chipot , C. , Skeel , R.D. , Kale , L. and Schulten , K. 2005 . Scalable molecular dynamics with NAMD . J. Comput. Chem. , 26 : 1781 – 1802 .
   PubMed Web of Science ®Google Scholar
• Morris , G.M. , Goodsell , D.S. , Halliday , R.S. , Huey , R. , Hart , W.E. , Belew , R.K. and Olson , A.J. 1998 . Automated docking using a Lamarckian genetic algorithm and and empirical binding free energy function . J. Comput. Chem. , 19 : 1639 – 1662 .
   Web of Science ®Google Scholar
• Hetényi , C. and Van der Spoel , D. 2006 . Blind docking of drug-sized compounds to proteins with up to a thousand residues . FEBS Lett. , 580 : 1447 – 1450 .
   PubMed Web of Science ®Google Scholar
• Huey , R. , Morris , G.M. , Olson , A.J. and Goodsell , D.S. 2007 . A semi-empirical free energy force field with charge-based desolvation . J. Comput. Chem. , 28 : 1145 – 1152 .
   PubMed Web of Science ®Google Scholar
• Laurie , A.T. and Jackson , R.M. 2005 . Q-SiteFinder: An energy-based method for the prediction of protein-ligand binding sites . Bioinformatics , 21 : 1908
   PubMed Web of Science ®Google Scholar
• Correa-Basurto , J. , Flores-Sandoval , C. , Marín-Cruz , J. , Rojo-Domínguez , A. , Espinoza-Fonseca , L.M. and Trujillo-Ferrara , J.G. 2007 . Docking and quantum mechanic studies of cholinesterase inhibitors . Eur. J. Med. Chem. , 42 : 10 – 19 .
   PubMed Web of Science ®Google Scholar
• Silva , C.H. and Taft , C.A. 2004 . Computer-aided molecular design of novel glucosidase inhibitors for AIDS treatment . J. Biomol. Struct. Dyn. , 22 : 59 – 63 .
   PubMed Web of Science ®Google Scholar
• De Amorim , H.L. , Caceres , R.A. and Netz , P.A. 2008 . Linear interaction energy (LIE) method in lead discovery and optimization . Curr. Drug Targets , 9 : 1100 – 1105 .
   Web of Science ®Google Scholar
• Alonso , H. , Bliznyuk , A.A. and Gready , J.E. 2006 . Combining docking and molecular dynamic simulations in drug design . Med. Res. Rev. , 26 : 531 – 568 .
   PubMed Web of Science ®Google Scholar
• Xiong , Y.Z. and Chen , P.Y. 2008 . ONIOM DFT/PM3 calculation on the interaction between STI-571 and abelson tyrosine kinase . J. Mol. Model. , 14 : 1083 – 1086 .
   PubMed Web of Science ®Google Scholar
• Kwiecień , R.A. , Ayadi , F. , Nemmaoui , Y. , Silvestre , V. , Zhang , B.L. and Robins , R.J. 2009 . Probing stereoselectivity and pro-chirality of hydride transfer during short-chain alcohol dehydrogenase activity: A combined quantitative 2H NMR and computational approach . Arch. Biochem. Biophys. , 482 : 42 – 51 .
   Web of Science ®Google Scholar
• Soriano-Ursúa , M.A. , Trujillo-Ferrara , J.G. and Correa-Basurto , J. 2010 . Docking studies on a refined human beta2 adrenoceptor model yield theoretical affinity values in function with experimental values for R-ligands, but not for S-antagonists . J. Mol. Model. , 16 : 401 – 409 .
   Web of Science ®Google Scholar
• Ho , B.K. and Agard , D.A. 2009 . Probing the flexibility of large conformational changes in protein structures through local perturbations . PLoS Comput. Biol. , 5 ( 4 ) : e1000343
   PubMed Web of Science ®Google Scholar
• Anzini , M. , Rovini , M. , Cappelli , A. , Vomero , S. , Manetti , F. , Botta , M. , Sautebin , L. , Rossi , A. , Pergola , C. , Ghelardini , C. , Norcini , M. , Giordani , A. , Makovec , F. , Anzellotti , P. , Patrignani , P. and Biava , M. 2008 . Synthesis, biological evaluation, and enzyme docking simulations of 1,5-diarylpyrrole-3-alkoxyethyl ethers as selective cyclooxygenase-2 inhibitors endowed with anti-inflammatory and antinociceptive activity . J. Med. Chem. , 14 : 4476 – 4481 .
   Web of Science ®Google Scholar
• Patel , S. , Jazrawi , E. , Creighton , A.M. , Austin , C.A. and Fisher , L.M. 2000 . Probing the interaction of the cytotoxic bisdioxopiperazine ICRF-193 with the closed enzyme clamp of human topoisomerase IIalpha . Mol. Pharmacol. , 58 : 560 – 568 .
   Web of Science ®Google Scholar
• Classen , S. , Olland , S. and Berger , J.M. 2003 . Structure of the topoisomerase II ATPase region and its mechanism of inhibition by the chemotherapeutic agent ICRF-187 . Proc. Natl Acad. Sci. USA , 100 : 10629 – 10634 . Epub 2003 Sep. Erratum in: Proc. Natl Acad. Sci. USA 100 (2003), p. 14510
   PubMed Web of Science ®Google Scholar
• Goldgur , Y. , Craigie , R. , Cohen , G.H. , Fujiwara , T. , Yoshinaga , T. , Fujishita , T. , Sugimoto , H. , Endo , T. , Murai , H. and Davies , D.R. 1999 . Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: A platform for antiviral drug design . Proc. Natl Acad. Sci. USA , 96 : 13040 – 13043 .
   PubMed Web of Science ®Google Scholar
• Healy , E.F. , Sanders , J. , King , P.J. and Robinson , W.E. Jr . 2009 . A docking study of L-chicoric acid with HIV-1 integrase . J. Mol. Graph. Model. , 27 : 584 – 589 .
   PubMed Web of Science ®Google Scholar
• Garcia , A.R. , de Barros , R.B. , Lourenço , J.P. and Ilharco , L.M. 2008 . The infrared spectrum of solid L-alanine: Influence of pH-induced structural changes . J. Phys. Chem. A , 112 : 8280 – 8287 .
   Web of Science ®Google Scholar